Ceria Therapeutics’ Post

Discover the potential of Sildenafil (Viagra) in combating Alzheimer's disease. Latest studies show promising results! Stay tuned for updates on clinical trials and how this could change the future of AD treatment. #AlzheimersResearch #InnovativeMedicine #HealthcareProgress #ClinicalTrials #Pharmacology

This #ALSAwarenessMonth, we are helping to raise awareness of the disease and showing our support for the caregivers, families, and patients who are affected. Passage Bio joins the fight against #ALS by continuing to work towards improving the lives of people with #neurodegenerativediseases: https://loom.ly/WkGeVEQ

It is wonderful to see another tool in our toolbox to aid to improve "ON" state and quality of life in individuals with Parkinson's disease. https://lnkd.in/gjkiYz2a

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?

👌 Coronavirus disease (COVID-19) is an infectious disease caused by a #newly discovered coronavirus. ⭕️ Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special #treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. ✅ Learn More from #FADIC Coronavirus Experimental Treatment https://lnkd.in/drnaffn3

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?

Rare disease research faces a common challenge: how do you study new treatments and advance research when there aren’t a lot of people living with the rare disease? And how do you incentivize drug development sponsors to invest in these important studies and encourage patients to participate in clinical trials?